levodopa has been researched along with fce 23884 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buonamici, M; Cervini, MA; Maj, R; Mantegani, S; Rossi, AC | 1 |
Blanchet, PJ; Chase, TN; de Jong, D; Metman, LV; Mouradian, MM | 1 |
1 trial(s) available for levodopa and fce 23884
Article | Year |
---|---|
Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2; Treatment Outcome | 1996 |
1 other study(ies) available for levodopa and fce 23884
Article | Year |
---|---|
A new dopamine agonist in dopamine deprived systems: FCE 23884.
Topics: Animals; Apomorphine; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Levodopa; Male; Mice; Motor Activity; Reserpine; Time Factors | 1992 |